REGISTERED NUMBER: 11772572 (England and Wales)

Unaudited Financial Statements

for the Year Ended 31 March 2025

for

CLINICAL METRICS LTD

PREVIOUSLY KNOWN AS

YELLOW BIRD CONSULTING LTD

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3

Directors:

T Raupach

C Morton

M Flitton

Registered office:

Building 423 - Sky View (Ro)

Argosy Road

East Midlands Airport

Derby

DE74 2SA

Registered number:

11772572 (England and Wales)

Accountants:

Cooper Parry Advisory Limited

Broadwalk House, 5th Floor

5 Appold Street

Broadgate

London

EC2A 2AG

Fixed assets

Tangible assets

4

6,482

9,262

Current assets

Debtors

5

38,192

7,820

Cash at bank

31,804

85,467

69,996

93,287

Creditors

Amounts falling due within one year

6

11,411

14,680

Net current assets

58,585

78,607

Total assets less current liabilities

65,067

87,869

Provisions for liabilities

1,232

-

Net assets

63,835

87,869

Capital and reserves

Called up share capital

7

3,000

3,000

Retained earnings

60,835

84,869

Shareholders' funds

63,835

87,869

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 10 December 2025 and were signed on its behalf by:

C Morton - Director

1.	Statutory information

Clinical Metrics Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).

2.	Accounting policies

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Fixtures and fittings

-

15% on reducing balance

Computer equipment

-

33% on cost and 25% on cost

Financial instruments

Financial assets and financial liabilities are recognised in the balance sheet when the company becomes a party to the contractual provisions of the instrument.

Trade and other debtors and creditors are classified as basic financial instruments and measured at initial recognition at transaction price. Debtors and creditors are subsequently measured at amortised cost using the effective interest rate method. A provision is established when there is objective evidence that the company will not be able to collect all amounts due.

Cash and cash equivalents are classified as basic financial instruments and comprise cash in hand and at bank and bank overdrafts.

Financial liabilities and equity instruments issued by the company are classified in accordance with the substance of the contractual arrangements entered into and the definitions of a financial liability and an equity instrument. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Equity instruments issued by the company are recorded at the proceeds received, net of direct issue costs.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and Loss Account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies

Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	Employees and directors

The average number of employees during the year was 1 (2024 - 3 ) .

4.	Tangible fixed assets

Fixtures

and

Computer

fittings

equipment

Totals

£

£

£

Cost

At 1 April 2024

237

15,346

15,583

Additions

-

3,190

3,190

Disposals

-

(1,124

)

(1,124

)

At 31 March 2025

237

17,412

17,649

Depreciation

At 1 April 2024

114

6,207

6,321

Charge for year

19

5,264

5,283

Eliminated on disposal

-

(437

)

(437

)

At 31 March 2025

133

11,034

11,167

Net book value

At 31 March 2025

104

6,378

6,482

At 31 March 2024

123

9,139

9,262

5.

Debtors: amounts falling due within one year

2025

2024

£

£

Trade debtors

28,153

-

Other debtors

10,039

7,820

38,192

7,820

6.

Creditors: amounts falling due within one year

2025

2024

£

£

Trade creditors

11,389

861

Taxation and social security

-

13,797

Other creditors

22

22

11,411

14,680

7.	Called up share capital

Allotted, issued and fully paid:

Number:

Class:

Nominal

2025

2024

value:

£

£

300,000

Ordinary

0.01

3,000

3,000

8.	Related party disclosures

At the year end there were amounts owed by directors of the company of £978 (2024: £978). These amounts are unsecured, interest free and repayable on demand.